Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term Safety and Efficacy of Mexiletine for Patients With Skeletal Muscle Channelopathies.

JAMA neurology - 1 Dec 2015

Suetterlin Karen Joan, Bugiardini Enrico, Kaski Juan P, Morrow Jasper M, Matthews Emma, Hanna Michael G, Fialho Doreen

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Electrocardiography
Share to Channelopathies
Share to Chloride Channels
Share to Dose-Response Relationship, Drug

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Longitudinal Studies

Share to Muscle, Skeletal

Share to NAV1.4 Voltage-Gated Sodium Channel

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 26658970
DOI: 10.1001/jamaneurol.2015.2338

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term Safety and Efficacy of Mexiletine for Patients With Skeletal Muscle Channelopathies.PMID 26658970Read ↗

Muscle channelopathies.Semantic proximity Read ↗

Muscle Channelopathies.Semantic proximity Read ↗

Drug repurposing in skeletal muscle ion channelopathies.Semantic proximity Read ↗

Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.Semantic proximity Read ↗

Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 TrialSemantic proximity Read ↗

Central/nervous system/neuromuscularchannelopathies.Semantic proximity Read ↗

Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.Semantic proximity Read ↗

Skeletal Muscle Channelopathies.Semantic proximity Read ↗

Skeletal Muscle ChannelopathiesSemantic proximity Read ↗

Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.Semantic proximity Read ↗

Clinical electrophysiologic tests and genotype correlations in muscle channelopathies.Semantic proximity Read ↗

Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.